STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 89 filers reported holding STOKE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | -98.1% | 2,681 | -94.7% | 0.00% | – |
| Q2 2023 | $537 | +448.0% | 50,555 | +374.3% | 0.00% | – |
| Q4 2022 | $98 | -98.6% | 10,658 | +4700.9% | 0.00% | – |
| Q3 2021 | $7,000 | 0.0% | 222 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -72.0% | 222 | -66.4% | 0.00% | – |
| Q1 2021 | $25,000 | -37.5% | 661 | -45.0% | 0.00% | – |
| Q3 2020 | $40,000 | +263.6% | 1,202 | +155.7% | 0.00% | – |
| Q2 2020 | $11,000 | +37.5% | 470 | +26.0% | 0.00% | – |
| Q1 2020 | $8,000 | – | 373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |